Literature DB >> 9804187

Regulation of the fibronectin EDA exon alternative splicing. Cooperative role of the exonic enhancer element and the 5' splicing site.

A F Muro1, A Iaconcig, F E Baralle.   

Abstract

Alternatively spliced exons generally contain weak splicing sites, and exonic and/or intronic regulatory elements recognised by trans-acting auxiliary splicing factors. The EDA exon of the fibronectin gene is a typical example of an exon bearing a purine-rich exon splicing enhancer (ESE) element recognised by members of the SR phosphoprotein family. The regulatory region that governs splicing in the human EDA exon also contains an exon splicing silencer (ESS) element. We have cloned the mouse EDA genomic region, and we show that the ESE and the ESS elements, although they have base differences, can be replaced by the human elements without significant change in the exon inclusion/exclusion ratio. This fact suggests a common splicing regulatory mechanism across species. We demonstrate in vivo the functional activity of the mouse ESE element in splicing. We also show that the trans-acting factors recognising this element cooperate with the 5' splicing site of the EDA exon to facilitate proper exon recognition. Indeed, a strong 5' splicing site overrides the ESE function in exon recognition. However, the presence of a strong 3' splicing site is not sufficient to compensate for the absence of the splicing enhancer. Our data provide in vivo evidence of the interplay between the exonic splicing regulatory elements and the splicing sites, leading finally to subtle regulation of alternative splicing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804187     DOI: 10.1016/s0014-5793(98)01201-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.

Authors:  C F Bourgeois; M Popielarz; G Hildwein; J Stevenin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK/Erk 1/2-dependent signaling.

Authors:  Martin Kohan; Andres F Muro; Eric S White; Neville Berkman
Journal:  FASEB J       Date:  2010-07-19       Impact factor: 5.191

3.  Differing patterns of selection in alternative and constitutive splice sites.

Authors:  Kavita Garg; Phil Green
Journal:  Genome Res       Date:  2007-06-07       Impact factor: 9.043

Review 4.  The myofibroblast matrix: implications for tissue repair and fibrosis.

Authors:  Franco Klingberg; Boris Hinz; Eric S White
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

Review 5.  Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity.

Authors:  Charles W Frevert; Jessica Felgenhauer; Malgorzata Wygrecka; Madalina V Nastase; Liliana Schaefer
Journal:  J Histochem Cytochem       Date:  2018-01-01       Impact factor: 2.479

6.  Vitamin A metabolite, all-trans-retinoic acid, mediates alternative splicing of protein kinase C deltaVIII (PKCdeltaVIII) isoform via splicing factor SC35.

Authors:  Hercules Apostolatos; André Apostolatos; Timothy Vickers; James E Watson; Shijie Song; Fernando Vale; Denise R Cooper; Juan Sanchez-Ramos; Niketa A Patel
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

7.  Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display.

Authors:  A F Muro; M Caputi; R Pariyarath; F Pagani; E Buratti; F E Baralle
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

8.  Control of fibroblast fibronectin expression and alternative splicing via the PI3K/Akt/mTOR pathway.

Authors:  Eric S White; Rommel L Sagana; Adam J Booth; Mei Yan; Ashley M Cornett; Christopher A Bloomheart; Jessica L Tsui; Carol A Wilke; Bethany B Moore; Jeffrey D Ritzenthaler; Jesse Roman; Andrés F Muro
Journal:  Exp Cell Res       Date:  2010-07-13       Impact factor: 3.905

9.  Protein kinase C δ (PKCδ) splice variants modulate apoptosis pathway in 3T3L1 cells during adipogenesis: identification of PKCδII inhibitor.

Authors:  Rekha Patel; André Apostolatos; Gay Carter; Joanne Ajmo; Meghanath Gali; Denise R Cooper; Min You; Kirpal S Bisht; Niketa A Patel
Journal:  J Biol Chem       Date:  2013-07-31       Impact factor: 5.157

Review 10.  New insights into form and function of fibronectin splice variants.

Authors:  E S White; F E Baralle; A F Muro
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.